Skip to main content
FinSpry Logo
FinSpry
ALKS logo
ALKS
(NASDAQ)
Alkermes plc
$52.97-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Alkermes (ALKS) Stock Price & Financial Analysis

Alkermes Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$51.69 - $53.54
52-Week High$55.67
52-Week Low$25.17
Open$52.13
Volume1.49M
Average Volume (3M)2.32M
Market Cap8.80B
Shares Outstanding166.20M
P/E Ratio (TTM)57.64
Forward P/E116.51
Price to Sales (P/S)5.63
Price to Book (P/B)5.03
EV/EBITDA36.30
Revenue (TTM)1.56B
Net Income (TTM)152.72M
Free Cash Flow (TTM)221.80M
EPS (TTM)$0.91
Profit Margin9.78%
Operating Margin12.28%
Return on Equity (ROE)8.72%
Debt to Equity0.90
50-Day MA$46.20
200-Day MA$34.92
52-Week Change94.81%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Alkermes

What is the current stock price for ALKS?

As of the latest trading session, ALKS stock trades at $52.97. The 52-week range is $25.17–$55.67, with a day range of $51.69–$53.54.

What is the P/E ratio for ALKS?

Alkermes's trailing P/E ratio is 57.6, meaning investors pay $57.6 for every $1 of annual earnings. The forward P/E is 116.5, reflecting analyst expectations for future earnings. Alkermes operates in the Healthcare sector.

Does ALKS pay dividends?

Alkermes does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALKS?

Based on 13 analysts, the consensus for ALKS is Buy.

What is the market cap of ALKS?

Alkermes's market capitalization is $8.80B, classifying it as a mid-cap company. Alkermes operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.